These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 21152016)

  • 1. NT-proBNP and circulating inflammation markers in prediction of a normal myocardial scintigraphy in patients with symptoms of coronary artery disease.
    Rathcke CN; Kjøller E; Fogh-Andersen N; Zerahn B; Vestergaard H
    PLoS One; 2010 Dec; 5(12):e14196. PubMed ID: 21152016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Coronary Atherosclerosis and Myocardial Ischemia on Plasma Levels of High-Sensitivity Troponin T and NT-proBNP in Patients With Stable Angina.
    Caselli C; Prontera C; Liga R; De Graaf MA; Gaemperli O; Lorenzoni V; Ragusa R; Marinelli M; Del Ry S; Rovai D; Giannessi D; Aguade-Bruix S; Clemente A; Bax JJ; Lombardi M; Sicari R; Zamorano J; Scholte AJ; Kaufmann PA; Knuuti J; Underwood SR; Clerico A; Neglia D
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):757-64. PubMed ID: 26868212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated NT-proBNP and coronary calcium score in relation to coronary artery disease in asymptomatic type 2 diabetic patients with elevated urinary albumin excretion rate.
    Reinhard H; Hansen PR; Persson F; Tarnow L; Wiinberg N; Kjær A; Petersen CL; Winther K; Parving HH; Rossing P; Jacobsen PK
    Nephrol Dial Transplant; 2011 Oct; 26(10):3242-9. PubMed ID: 21372253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronary artery calcium score and N-terminal pro-B-type natriuretic peptide as potential gatekeepers for myocardial perfusion imaging.
    Haarmark C; Andersen KF; Madsen C; Zerahn B
    Clin Physiol Funct Imaging; 2017 Nov; 37(6):710-716. PubMed ID: 27005324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum YKL-40 predicts long-term mortality in patients with stable coronary disease: a prognostic study within the CLARICOR trial.
    Harutyunyan M; Gøtze JP; Winkel P; Johansen JS; Hansen JF; Jensen GB; Hilden J; Kjøller E; Kolmos HJ; Gluud C; Kastrup J
    Immunobiology; 2013 Jul; 218(7):945-51. PubMed ID: 23294528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [N-terminal pro-brain natriuretic peptide (NT-proBNP) and ischemia modified albumin (IMA) in exercise induced ischemia in patients with stable coronary artery disease].
    Piechota WN; Wierzbowski R; Piechota WT; Bejm J; Gielerak G
    Pol Arch Med Wewn; 2006 Jul; 116(1):640-7. PubMed ID: 17340970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-terminal-proB natriuretic peptide in patients with stable coronary artery disease evaluated for ischemia with myocardial perfusion imaging.
    Majstorov V; Pop GD; Vavlukis M; Peovska I; Maksimovik J; Vaskova O; Kuzmanovska S; Zdraveska-Kochovska M
    Bratisl Lek Listy; 2008; 109(7):293-7. PubMed ID: 18792482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-terminal pro-B-type natriuretic Peptide predicts significant coronary artery lesion in the unstable angina patients with normal electrocardiogram, echocardiogram, and cardiac enzymes.
    Hong SN; Yoon NS; Ahn Y; Lim SY; Kim YS; Yun KH; Kang DK; Lee SH; Lee YS; Kim KH; Son IS; Hong YJ; Park HW; Kim JH; Jeong MH; Cho JG; Park JC; Kang JC
    Circ J; 2005 Dec; 69(12):1472-6. PubMed ID: 16308494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limited utilities of N-terminal pro B-type natriuretic peptide and other newer risk markers compared with traditional risk factors for prediction of significant angiographic lesions in stable coronary artery disease.
    Peer A; Falkensammer G; Alber H; Kroiss A; Griesmacher A; Ulmer H; Pachinger O; Mair J
    Heart; 2009 Feb; 95(4):297-303. PubMed ID: 18708421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic changes in N-terminal pro-brain natriuretic peptide in acute coronary syndromes treated with percutaneous coronary intervention: a marker of ischemic burden, reperfusion and outcome.
    Buchner S; Debl K; Barlage S; Griese D; Fredersdorf S; Jeron A; Lubnow M; Müller T; Muders F; Holmer S; Riegger GA; Luchner A
    Clin Chem Lab Med; 2010 Jun; 48(6):875-81. PubMed ID: 20441480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-terminal pro-brain natriuretic peptide used for the prediction of coronary artery stenosis.
    Wolber T; Maeder M; Rickli H; Riesen W; Binggeli C; Duru F; Ammann P
    Eur J Clin Invest; 2007 Jan; 37(1):18-25. PubMed ID: 17181563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of combined high-sensitive C-reactive protein and N-terminal-probrain natriuretic peptide for predicting cardiovascular events in patients with suspected coronary artery disease.
    Huang PH; Lu TM; Wu TC; Lin FY; Chen YH; Chen JW; Lin SJ
    Coron Artery Dis; 2008 May; 19(3):187-93. PubMed ID: 18418236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiopoietin-2 provides no incremental predictive value for the presence of obstructive coronary artery disease over N-terminal pro-brain natriuretic peptide.
    Jian W; Mo CH; Yang GL; Li L; Gui C
    J Clin Lab Anal; 2019 Oct; 33(8):e22972. PubMed ID: 31257664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of N-terminal Pro-brain Natriuretic Peptide and Myocardial Perfusion in Asymptomatic Adults (from the Multi-Ethnic Study of Atherosclerosis).
    Mitchell A; Misialek JR; Folsom AR; Duprez D; Alonso A; Jerosch-Herold M; Sanchez OA; Watson KE; Sallam T; Konety SH
    Am J Cardiol; 2015 May; 115(10):1341-5. PubMed ID: 25816778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Head-to-Head Comparison of the Incremental Predictive Value of The Three Established Risk Markers, Hs-troponin I, C-Reactive Protein, and NT-proBNP, in Coronary Artery Disease.
    Nikorowitsch J; Ojeda F; Lackner KJ; Schnabel RB; Blankenberg S; Zeller T; Karakas M
    Biomolecules; 2020 Mar; 10(3):. PubMed ID: 32143410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of postmortem measurement of NT-proBNP as a marker for cardiac function.
    Michaud K; Augsburger M; Donzé N; Sabatasso S; Faouzi M; Bollmann M; Mangin P
    Int J Legal Med; 2008 Sep; 122(5):415-20. PubMed ID: 18553094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of Serum Nt-Pro Bnp Levels and Myocardial Performance Index in Asymptomatic Type 2 Diabetics for Assessment of Myocardial Ischaemia.
    Kumar G; Lal MK; Singh G; Naik D
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of N-terminal pro-brain natriuretic peptide in elderly people with acute myocardial infarction: prospective observational study.
    Lorgis L; Zeller M; Dentan G; Sicard P; Buffet P; L'Huillier I; Beer JC; Vincent-Martin M; Makki H; Gambert P; Cottin Y;
    BMJ; 2009 May; 338():b1605. PubMed ID: 19420032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-terminal B-type natriuretic peptide predicts extent of coronary artery disease and ischemia in patients with stable angina pectoris.
    Weber M; Dill T; Arnold R; Rau M; Ekinci O; Müller KD; Berkovitsch A; Mitrovic V; Hamm C
    Am Heart J; 2004 Oct; 148(4):612-20. PubMed ID: 15459591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-terminal pro-B-type natriuretic peptide for predicting coronary disease and left ventricular hypertrophy in asymptomatic CKD not requiring dialysis.
    DeFilippi CR; Fink JC; Nass CM; Chen H; Christenson R
    Am J Kidney Dis; 2005 Jul; 46(1):35-44. PubMed ID: 15983955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.